It is expected to provide guidance on licensing, clinical trial pathways, quality systems, regulatory compliance and market access, helping bridge the gap between innovation and implementation.
The Government Institute of Medical Sciences (GIMS) has established Uttar Pradesh’s first MedTech Regulatory Clinic at its Centre for Medical Innovation (CMI), in collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), aiming to support emerging healthcare technology startups in India.
The clinic was inaugurated by Dr G. N. Singh, former Drug Controller General of India and Advisor to the Chief Minister of Uttar Pradesh.
He described the initiative as a significant milestone for the state’s healthcare and innovation landscape, stating that India’s MedTech sector requires not only innovation but also strong regulatory and policy support to transform ideas into market-ready healthcare solutions.
Sonia Gandhi, Deputy General Manager and Head of Regulatory Affairs and Policy Advocacy (RAPA) at BIRAC, attended the event as the Guest of Honour and conducted the first mentoring session for startups.
The session focused on regulatory approvals, quality standards, policy frameworks, clinical validation procedures and strategies for commercialization of indigenous technologies.
During the visit, Dr G. N. Singh interacted with startups incubated at GIMS, including Matri, which has completed clinical trials at the institute.
Dr Rahul, CEO of the Centre for Medical Innovation, stated that the clinic has been designed to create an integrated support system where startups can access incubation, mentorship and clinical validation under one platform.
The Director of GIMS also reiterated the institute’s focus on advancing research-driven, affordable and technology-enabled healthcare solutions.
The initiative builds on GIMS’s selection as a BIRAC-RAPA Nodal Centre under the Delhi-NCR network, alongside institutions such as AIIMS, IIT Delhi and the Regional Centre for Biotechnology.
As one of only four selected centres, GIMS is positioned to play a key role in supporting healthcare innovation and regulatory facilitation.
Officials indicated that the MedTech Regulatory Clinic will act as a facilitation platform for innovators, clinicians, researchers and entrepreneurs.
It is expected to guide licensing, clinical trial pathways, quality systems, regulatory compliance and market access, helping bridge the gap between innovation and implementation.
Stay tuned for more such updates on Digital Health News
